Familial hypercholesterolemia from children to adults

Cardiovascular Drugs and Therapy

Volumn 16, Issue 4, 2002, Pages 289-293

  Ose, Leiv ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Children; DNA diagnosis; Familial hypercholesterolemia; LDL cholesterol; LDL receptor

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; DNA; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; STATINE;

ADULT; AGE DISTRIBUTION; ATHEROSCLEROSIS; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DIETARY INTAKE; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; HUMAN; LOW FAT DIET; MONOGENIC DISORDER; PRIORITY JOURNAL; RECEPTOR GENE; SOCIAL PSYCHOLOGY;

ADULT; ANTICHOLESTEREMIC AGENTS; CHILD; CHOLESTEROL, LDL; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MUTATION; PSYCHOLOGY; RECEPTORS, LDL;

EID: 0036988364     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021773724477     Document Type: Conference Paper

References (12)

1. Calandra S, Defesche J, Faergeman O, et al. Familial Hypercholesterolemia (FH). Report of a WHO Consultation, Geneve, 1998:1-68.
2. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CT, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, New York: McGraw-Hill, 1995:1981-2030.
3. Tybjaerg-Hansen A, Humphries SE. Familial defective apolipoprotein B-100: A single mutation that causes hypercholesterolemia and premature coronary artery disease. Atherosclerosis 1992;96:91-107.
4. Winder AF, Day LB, F. BP. Premature corneal arcus in familial hypercholesterolaemia is characteristic but not a marker of individual coronary risk [abstract]. Atherosclerosis 1997;134:48.
5. Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolemia. Br Med J 1991:303:893-896.
6. Illingworth DR, Duell PB, Connor WE. Disorders of lipid metabolism. In: Endocrinology and Metabolism 1995:1315-1405.
7. Connor WE, Connor SL. Importance of diet in the treatment of familial hypercholesterolemia. Am J Cardiol 1993;72:42D-53D.
8. Tonstad S, Sivertsen M. Food dislikes and dietary intake of children with familial hypercholesterolemia and controls. Scand J Nutr 1996;40:146-150.
9. Ose L, Tonstad S. The detection and management of dyslipidaemia in children and adolescents. Acta Pœdiatr 1995;84:1213-1215.
10. Ose L, Tonstad S, Vesterhus P, Wefring KW. Detection and management of familial hypercholesterolemia in children and adolescents. Tidsskr Nor Lœgeforen 1995;115:3499-3503.
11. Williams RR, Hamilton-Craig I, Kostner GM, et al. MEDPED: An integrated genetic strategy for preventing early deaths. In: Berg K, Boulyjenkov V, Christen Y, eds. Genetic Approaches to Noncommunicable Diseases. Berlin: Springer-Verlag, 1996.
12. Miserez A, Keller U. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995;15:1719-1729.